Direct medical costs for surgical and medical treatment of condylomata acuminata

Arch Dermatol. 2001 Mar;137(3):337-41.

Abstract

Objective: To determine which treatment modalities for condylomata acuminata are associated with the lowest direct medical costs.

Design: Cost-effectiveness analysis.

Setting: Ambulatory private practice, primary or specialty care.

Patients or other participants: Adults with no presenting complaints other than condylomata acuminata.

Interventions: Construction of a cost-effectiveness model. From a literature review, extraction of commonly accepted guidelines regarding duration and frequency as well as reports of efficacies of typical treatment regimens; from Medicare physician fee schedules, costs of physician visits and physician-administered treatments; from published data, average wholesale prices of medications.

Main outcome measure: Estimated direct medical costs per complete clearance associated with different treatment options for condylomata acuminata.

Results: Mean direct medical costs per complete clearance are lowest for surgical excision ($285). Other low-cost modalities are loop electrosurgical excision procedure ($316), electrodesiccation ($347), carbon dioxide laser ($416), podofilox ($424), and pulsed-dye laser ($479). Higher-cost modalities are cryotherapy ($951), trichloroacetic acid ($986), imiquimod ($1255), podophyllum resin ($1632), and interferon alfa-2b ($6665).

Conclusion: Surgical modalities, including excision, electrodesiccation, loop electrosurgical excision procedure, and laser, as well as podofilox are low-cost options for the treatment of condylomata acuminata.

MeSH terms

  • Condylomata Acuminata / economics*
  • Condylomata Acuminata / surgery
  • Condylomata Acuminata / therapy*
  • Cost-Benefit Analysis
  • Drug Costs
  • Female
  • Health Care Costs
  • Humans
  • Male
  • Office Visits / economics
  • United States